ICL Q3 2025 Earnings Call Summary

1Key Financial Results and Metrics

Sales: $1.853 billion, up 6% year-over-year.

Specialties-driven Businesses Sales: $1.461 billion, up 3%.

Adjusted EBITDA: $398 million, improved 4% year-over-year and up 13% sequentially.

Adjusted Diluted Earnings Per Share: $0.10.

Operating Cash Flow: $308 million, an increase of nearly $40 million sequentially.

Dividend Distribution: $62 million, yielding a trailing 12-month dividend yield of 2.8%.

Net Debt to Adjusted EBITDA Ratio: 1.4x.

2Strategic Updates and Business Highlights

MOU with Israel: Signed an MOU regarding the Dead Sea concession, providing regulatory clarity and compensation of approximately $2.54 billion if ICL does not win the new concession, which is seen as a proactive step.

Potash Division: Sales of $453 million with EBITDA of $169 million; average potash price increased by 20% year-over-year.

Phosphate Solutions: Sales of $605 million, up 5% year-over-year; strong demand for specialty food phosphates.

Growing Solutions: Sales of $561 million, up 4% year-over-year; challenges in Brazil due to low farmer affordability and increased raw material costs.

Strategic Focus: Emphasis on profitable growth in Specialty Crop Nutrition and Specialty Food Solutions, with plans for acquisitions and portfolio optimization.

3Forward Guidance and Outlook

2025 Guidance: Maintaining EBITDA expectations between $0.95 billion and $1.15 billion for specialties-driven businesses; potash sales volumes projected between 4.3 million and 4.5 million metric tons.

Market Trends: Anticipated growth in specialty fertilizers and food solutions, with a focus on biostimulants and nutrient efficiency.

4Bad News, Challenges, or Points of Concern

Regional Performance Variability: Mixed sentiment across regions; Brazil facing significant challenges with farmer affordability and credit availability.

Raw Material Costs: Rising costs, particularly for sulfur, are expected to impact margins.

Market Sentiment: Concerns regarding the construction market and overall economic conditions, particularly in Europe and China, which may affect future performance.

5Notable Q&A Insights

Specialty Crop Nutrition: Management indicated potential for improved margins through R&D and a shift towards more profitable product mixes, including biostimulants.

Food Solutions Expansion: Plans to grow beyond phosphate-based solutions through both organic growth and acquisitions.

Market Dynamics in Brazil: Management acknowledged the tight credit situation for farmers and its impact on sales, but expressed confidence in Brazil's long-term agricultural potential.

MOU Market Reaction: Management clarified that the MOU is a positive development, providing clarity and compensation, and emphasized ICL's strong position to secure the next concession. Overall, ICL reported a solid quarter with strategic initiatives aimed at long-term growth, despite facing challenges in specific markets and rising costs. The management remains optimistic about future opportunities while navigating current headwinds.